cannabis indica

Índice completo — página 37 de 77

Estudos 3.601 a 3.700 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2020 a 2019. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 3.601 a 3.700

  1. 2020

    Use of Cannabis for Self-Management of Chronic Pelvic Pain

    FavorávelMetanáliseDorDor — Crônica
  2. 2020

    Use of complementary therapies for chronic pain management in patients with reported Ehlers-Danlos syndrome or hypermobility spectrum disorders

    FavorávelMetanáliseSíndrome de Ehlers-Danlos
  3. 2020

    Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath

    FavorávelEstudo LaboratorialCanabinol (CBN)Tetraidrocanabivarina (THCV)
  4. 2020

    Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian children

  5. 2020

    Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  6. 2020

    Warfarin dose adjustment required after cannabidiol initiation and titration

    InconclusivoMetanáliseDistúrbios de Coagulação
  7. 2020

    Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet

  8. 2020

    β-caryophyllene alleviates cerebral ischemia/ reperfusion injury in mice by activating autophagy

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  9. 2020

    β-caryophyllene improves sexual performance via modulation of crucial enzymes relevant to erectile dysfunction in rats

    InconclusivoEstudo em AnimaisLibidoDisfunção Erétil
  10. 2020

    β-Caryophyllene nanoparticles design and development: Controlled drug delivery of cannabinoid CB2 agonist as a strategic tool towards neurodegeneration

    FavorávelEstudo LaboratorialDoenças Neurodegenerativas
  11. 2020

    β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Nicotina
  12. 2020

    Δ 9 -Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    FavorávelEstudo em AnimaisEsclerose Múltipla2-Araquidonoilglicerol (2-AG)
  13. 2020

    Δ 9-Tetrahydrocannabinol (THC) Impairs CD8 + T Cell-Mediated Activation of Astrocytes

    FavorávelEstudo LaboratorialInflamação
  14. 2020

    Δ 9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaTHC Farmacêutico
  15. 2020

    Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression

    FavorávelEstudo em AnimaisCOVID-19
  16. 2020

    Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes

  17. 2019

    “Cannabis hyperemesis” causation questioned

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  18. 2019

    “HASH”ing out pancreatitis: the new increasingly common culprit

    DesfavorávelMetanálisePancreatite
  19. 2019

    2-Arachidonoylglycerol Mobilizes Myeloid Cells and Worsens Heart Function After Acute Myocardial Infarction

  20. 2019

    24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone

  21. 2019

    A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP

  22. 2019

    A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?

  23. 2019

    A case study for the use of medical cannabis in generalized anxiety disorder

    FavorávelMetanáliseAnsiedade
  24. 2019

    A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis

  25. 2019

    A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety

    InconclusivoMetanáliseDorCâncerEpilepsiaCBD Farmacêutico+2
  26. 2019

    A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain

    InconclusivoMetanáliseDorDor — Crônica
  27. 2019

    A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoInsônia e Distúrbios do SonoPalmitoiletanolamida (PEA)
  28. 2019

    A Fragrant Environment Containing α-Pinene Suppresses Tumor Growth in Mice by Modulating the Hypothalamus/Sympathetic Nerve/Leptin Axis and Immune System

    FavorávelEstudo em AnimaisCâncerCâncer — Melanoma
  29. 2019

    A hunger for hunger: A review of palliative therapies for cancer-associated anorexia

    FavorávelMetanáliseAnorexia (perda de apetite)Perda de Apetite
  30. 2019

    A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults

    FavorávelMetanáliseAsma
  31. 2019

    A meta-analytic investigation of the associations between cannabis use and cannabis-related negative consequences

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  32. 2019

    A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products

    FavorávelMetanáliseDorDor — CrônicaTHC FarmacêuticoTHC:CBD Farmacêutico+1
  33. 2019

    A new target to ameliorate the damage of periodontal disease: The role of transient receptor potential vanilloid type-1 in contrast to that of specific cannabinoid receptors in rats

  34. 2019

    A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions

    FavorávelEstudo LaboratorialDorInflamaçãoDoenças Cardiovasculares (DCV)+8
  35. 2019

    A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects

  36. 2019

    A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome

    FavorávelEnsaio ClínicoSíndrome do X FrágilCBD Farmacêutico
  37. 2019

    A Pilot Study of a Medical Cannabis - Opioid Reduction Program

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+1
  38. 2019

    A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Síndrome da Dor Central
  39. 2019

    A randomised controlled trial of vaporised Δ 9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  40. 2019

    A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

  41. 2019

    A Rare Case of Cannabis-induced Acute Pancreatitis

    DesfavorávelMetanálisePancreatite
  42. 2019

    A Review of Cannabis in Chronic Kidney Disease Symptom Management

    FavorávelMetanáliseDoença Renal CrônicaTHC:CBD Farmacêutico
  43. 2019

    A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC

  44. 2019

    A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients

  45. 2019

    A survey of veterinary student attitudes concerning whether marijuana could have therapeutic value for animals

    FavorávelMetanáliseAplicações Veterinárias
  46. 2019

    A systematic review of cannabidiol dosing in clinical populations

    FavorávelMetanálise ClínicaDorDependência — CannabisAnsiedade+15
  47. 2019

    A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars

    FavorávelMetanáliseDoenças de PeleFibrosePsoríase+1
  48. 2019

    Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção Cognitiva
  49. 2019

    Acute cannabis toxicity

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  50. 2019

    Acute effect of vaporized Cannabis on sleep and electrocortical activity

    FavorávelEstudo em AnimaisInsônia e Distúrbios do Sono
  51. 2019

    Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaEsquizofrenia
  52. 2019

    Acute Effects of Essential Oil Blend Containing Phlai Oil on Mood Among Healthy Male Volunteers: Randomized Controlled Trial

    FavorávelEnsaio ClínicoAnsiedadeMedicina Mente-Corpo
  53. 2019

    Acute naloxone-precipitated morphine withdrawal elicits nausea-like somatic behaviors in rats in a manner suppressed by N-oleoylglycine

  54. 2019

    Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDisfunção CognitivaTHC Farmacêutico+1
  55. 2019

    Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome

  56. 2019

    Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment.

    FavorávelEstudo LaboratorialEfeitos Adversos da Cannabis
  57. 2019

    Adolescent cannabis use and its associations with decision-making and episodic memory: Preliminary results from a longitudinal study

    DesfavorávelMetanáliseDisfunção Cognitiva
  58. 2019

    Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood

    DesfavorávelEstudo em AnimaisDisfunção Cognitiva
  59. 2019

    Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus

  60. 2019

    Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies

  61. 2019

    Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues

    DesfavorávelMetanáliseGestação
  62. 2019

    Age‐varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults

    DesfavorávelMetanáliseDependência — CannabisAnsiedadeDepressão+1
  63. 2019

    Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoEstresse OxidativoDoenças NeurodegenerativasTHC Farmacêutico+1
  64. 2019

    Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R)

    InconclusivoMetanáliseHepatite
  65. 2019

    An Integrated Review of Cannabis and Cannabinoids in Adult Oncologic Pain Management

    FavorávelMetanáliseDorDor — Oncológica
  66. 2019

    An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care

    FavorávelEnsaio ClínicoCuidados Paliativos
  67. 2019

    An overview of the adverse effects of cannabis use for Canadian physicians

  68. 2019

    An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use

    InconclusivoMetanáliseDependência — Cannabis
  69. 2019

    Analgesic Effect of α-Terpineol on Neuropathic Pain Induced by Chronic Constriction Injury in Rat Sciatic Nerve: Involvement of Spinal Microglial Cells and Inflammatory Cytokines

    FavorávelEstudo em AnimaisDorDor — Neuropatia PeriféricaDor — Neuropatia Diabética
  70. 2019

    Anandamide Is Related to Clinical and Cardiorespiratory Benefits of Aerobic Exercise Training in Migraine Patients: A Randomized Controlled Clinical Trial

    FavorávelEnsaio ClínicoEnxaquecaAnandamida (AEA)Exercício Físico
  71. 2019

    Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain

  72. 2019

    Anticancer Effects of n-3 EPA and DHA and Their Endocannabinoid Derivatives on Breast Cancer Cell Growth and Invasion

    FavorávelEstudo LaboratorialCâncerCâncer — MamaOutros Compostos Relacionados
  73. 2019

    Anticonvulsant Essential Oils and Their Relationship with Oxidative Stress in Epilepsy

    FavorávelMetanáliseEpilepsiaEstresse Oxidativo
  74. 2019

    Antidiarrheal Activity of α-Terpineol in Mice

    FavorávelEstudo em AnimaisDiarreia
  75. 2019

    Antimicrobial activity of Cannabis sativa, Thuja orientalis and Psidium guajava leaf extracts against methicillin-resistant Staphylococcus aureus

    FavorávelEstudo LaboratorialInfecções Bacterianas
  76. 2019

    Antimicrobial Activity of Essential Oil of Baccharis dracunculifolia DC (Asteraceae) Aerial Parts at Flowering Period

  77. 2019

    Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: impact of drug and fixed-dose ratio

  78. 2019

    Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer

  79. 2019

    Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  80. 2019

    Application device for THC:CBD oromucosal spray in the management of resistant spasticity: pre-production testing

    FavorávelEnsaio ClínicoEsclerose MúltiplaTHC:CBD Farmacêutico
  81. 2019

    Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?

  82. 2019

    Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in humans

    FavorávelEnsaio Clínico Duplo-CegoDistrofia Muscular e Distúrbios MiotônicosCBD Farmacêutico
  83. 2019

    Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells

  84. 2019

    Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma

  85. 2019

    Association between cannabis laws and opioid prescriptions among privately insured adults in the US

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  86. 2019

    Association Between Cannabis Use and Complications Related to Crohn's Disease: A Retrospective Cohort Study

    FavorávelMetanáliseDII — Doença de Crohn
  87. 2019

    Association between cannabis use and complications related to ulcerative colitis in hospitalized patients

  88. 2019

    Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes

    DesfavorávelMetanáliseDorDor — Neuropatia Diabética
  89. 2019

    Association between medical cannabis laws and opioid overdose mortality has reversed over time

    DesfavorávelMetanáliseDependência QuímicaDependência — Opioides
  90. 2019

    Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes

    DesfavorávelMetanáliseGestação
  91. 2019

    Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis

    DesfavorávelMetanáliseAnsiedadeDepressãoTentativa de Suicídio
  92. 2019

    Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis

    InconclusivoMetanáliseDisfunção CognitivaPsicoseDoenças Neurodegenerativas+1
  93. 2019

    Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  94. 2019

    Association of smoked cannabis with treatment resistance in schizophrenia

    DesfavorávelMetanáliseEsquizofrenia
  95. 2019

    Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)Síndrome Metabólica
  96. 2019

    Associations between state-level policy liberalism, cannabis use, and cannabis use disorder from 2004 to 2012: Looking beyond medical cannabis law status

    InconclusivoMetanáliseDependência — Cannabis
  97. 2019

    Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being

    InconclusivoMetanáliseGestação
  98. 2019

    Attentional bias, craving and cannabis use in an inpatient sample of adolescents and young adults diagnosed with cannabis use disorder: The moderating role of cognitive control

    InconclusivoMetanáliseDependência — Cannabis
  99. 2019

    Attenuating Effect of α-Pinene on Neurobehavioural Deficit, Oxidative Damage and Inflammatory Response Following Focal Ischaemic Stroke in Rat

    FavorávelEstudo em AnimaisAVC
  100. 2019

    Attenuation Effects of Alpha-Pinene Inhalation on Mice With Dizocilpine-Induced Psychiatric-Like Behaviour

    FavorávelEstudo em AnimaisEsquizofrenia